Drug
Kin 2787
Kin 2787: highest development phase Phase 1, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| KIN-2787 NCT04913285 | Phase 1 | Solid Tumor, Adult |
Latest
No recent events.
Follow Kin 2787 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.